Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cancer therapies
Biotech
Boehringer buys bacterial cancer therapy biotech in $500M deal
Boehringer Ingelheim is acquiring bacterial cancer therapy company T3 Pharmaceuticals in a deal that could be worth up to $508M.
Gabrielle Masson
Nov 22, 2023 10:21am
Leal Health adds FDA-approved cancer treatment decision support
Jun 22, 2023 4:30am
Bayer opens new $140M cancer research center in US
Jun 29, 2022 11:05am
New target uncovered for hard-to-treat cancers
Jun 6, 2022 12:07pm
Oncology biotech Atreca culls 25% of staff
Jun 2, 2022 10:34am
Unraveling how prostate tumors develop drug resistance
May 23, 2022 10:20am
